Aligos TherapeuticsALGS
13F holders, Q2 2025 (June 30)At the end of Q2 2025, 37 institutions reported holding Aligos Therapeutics Inc. (ALGS) in their 13F filings, up 2 from Q1 2025. 9 opened new positions and 7 sold out. The largest holders were Woodline Partners LP ($3.7M), Deep Track Capital, LP ($3.2M) and Alyeska Investment Group, L.P. ($3.0M). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Aligos Therapeutics Inc.
- CUSIP
- 01626L204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $755K |
| Exits | 7 | $5.4M |
All 13F filers, Q1 2025 → Q2 2025: 588,725 shares bought and 1,178,120 shares sold, net −589,395 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 37 holders
| Woodline Partners LP | 0.02% | Add +64.3% | 518,300 | $3.7M |
| Deep Track Capital, LP | 0.10% | No change | 444,110 | $3.2M |
| Alyeska Investment Group, L.P. | 0.01% | No change | 412,000 | $3.0M |
| Sio Capital Management, LLC | 0.97% | Add +85.9% | 335,937 | $2.4M |
| Tang Capital Management LLC | 0.05% | No change | 141,131 | $1.0M |
| Adage Capital Partners Gp, L.L.C. | 0.00% | Reduce -69.9% | 140,000 | $1.0M |
| Vanguard Group Inc. | 0.00% | Reduce -0.7% | 139,776 | $1.0M |
| Readystate Asset Management LP | 0.07% | Add +201.3% | 136,782 | $986K |
| Baker Bros. Advisors LP | 0.01% | No change | 83,055 | $599K |
| HHLR Advisors, LTD. | 0.02% | No change | 76,247 | $550K |
| Renaissance Technologies | 0.00% | Add +32.8% | 52,544 | $379K |
| Geode Capital Management, LLC | 0.00% | Add +21.3% | 34,048 | $246K |
| LPL Financial LLC | 0.00% | New | 30,100 | $217K |
| Charles Schwab Investment Management Inc. | 0.00% | Add +100.2% | 25,398 | $183K |
| Squarepoint Ops LLC | 0.00% | New | 18,589 | $134K |
| Citadel Advisors | 0.00% | New | 15,198 | $110K |
| XTX Topco Ltd | 0.00% | New | 13,849 | $100K |
| Wells Fargo & Company | 0.00% | Reduce -40.2% | 13,770 | $99K |
| BlackRock, Inc. | 0.00% | No change | 13,040 | $94K |
| Millennium Management | 0.00% | New | 12,315 | $89K |
| Two Sigma Investments, LP | 0.00% | Add +9.3% | 12,073 | $87K |
| Goldman Sachs Group Inc. | 0.00% | New | 10,231 | $74K |
| AlphaQuest LLC | 0.00% | Reduce -62.3% | 5,943 | $43K |
| Morgan Stanley | 0.00% | Reduce -46.6% | 4,005 | $29K |
| Acadian Asset Management LLC | 0.00% | New | 3,913 | $28K |
| UBS Group AG | 0.00% | Reduce -67.6% | 2,743 | $20K |
| Golden State Wealth Management, LLC | 0.00% | No change | 2,674 | $19K |
| Bank of America Corp. | 0.00% | Reduce -98.3% | 2,612 | $19K |
| Royal Bank of Canada | 0.00% | No change | 2,125 | $15K |
| BNP Paribas Financial Markets | 0.00% | Add +60433.3% | 1,816 | $13K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -9.7% | 1,103 | $8K |
| Raymond James Financial Inc. | 0.00% | New | 500 | $4K |
| Osaic Holdings, Inc. | 0.00% | No change | 220 | $2K |
| JPMorgan Chase & Co. | 0.00% | No change | 26 | $187 |
| SBI Securities Co., Ltd. | 0.00% | Add +62.5% | 26 | $187 |
| FMR LLC | 0.00% | New | 10 | $72 |
| Elevation Wealth Partners, LLC | 0.00% | No change | 4 | $29 |
"% of holder's portfolio" is ALGS's weight in each manager's 13F, not the share of Aligos Therapeutics Inc. the manager owns.